Surgical Innovations Group Plc logo

Surgical Innovations Group Plc(LSE) SUN

Market Cap£3.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-99%
5 Year-83%
1 Year-30%
1 Month-6%
£0.00
+12.50%
+0.00Today
Surgical Innovations Group Plc last closing stock price
MetricPriceDate
Last closeGBX 0.402026-10-01
Surgical Innovations Group Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.88%GBX 0.432026-09-24
1 month-5.88%GBX 0.432026-09-01
3 month-20%GBX 0.502026-07-03
Year to date-11.11%GBX 0.452025-12-31
1 year-30.43%GBX 0.582025-10-01
3 year-65.22%GBX 1.152023-10-02
5 year-82.98%GBX 2.352021-10-01
Since inception-99.48%GBX 0.771992-01-02

Surgical Innovations Group Plc Financials at a Glance

Market Cap

£3.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£23.39M

Net Income (TTM)

-£2.60M

EPS (TTM)

-£0.00

P/E Ratio

-3.33

Dividend

£0.00

Beta (Volatility)

0.06 (Low)

Price

£0.00

Volume

48,274

Open

£0.00

Previous Close

£0.00

Daily Range

£0.00 - £0.00

52-Week Range

£0.00 - £0.01

Estimated Earnings Date

Mar 25, 2027

SUN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Surgical Innovations Group Plc

Surgical Innovations Group plc is an international company specializing in the design, development, manufacturing, and marketing of devices for minimally invasive surgery. Established in 1988 and headquartered in Leeds, the company operates across various global markets, including the UK, Europe, Asia Pacific, and the United States.

Products and Services
  • SI-branded minimally invasive instruments, including YelloPort Elite and LogiRange systems
  • OEM services for third-party medical device firms
  • Distribution of medical products through Elemental Healthcare Ltd
Growth Outlook
  • Recent quarterly revenue of £5.46 million shows potential for recovery
  • Gross profit margin improved to 20.7% in Q4 2025
  • Positive cash flow from operating activities of £808,000 in Q4 2025
Financial Highlights
  • Trailing twelve months (TTM) revenue of £22.5 million
  • Current ratio of 1.48 indicates strong short-term financial health
  • Net income of -£916,000 in Q4 2025 reflects ongoing challenges
Surgical Innovations Group plc operates through three divisions: SI Brand, OEM, and Distribution, each contributing to its diverse product offerings. The company has shown resilience, with recent quarterly revenue indicating a potential turnaround. The gross profit margin has improved, suggesting better cost management and operational efficiency. Despite facing challenges, the positive cash flow from operating activities in the latest quarter highlights the company's ability to generate cash, which is crucial for sustaining operations and funding future growth initiatives. The current ratio further emphasizes the company's short-term financial stability, making it an intriguing option for investors interested in the medical devices sector.
AI Generated • Sep 26, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

David John Marsh

Website

sigroupplc.com

Headquarters

Leeds, YO LS16 6QZ, GB

SUN Financials

Key Financial Metrics (TTM)

Gross Margin

25.10%

Operating Margin

-8.88%

Net Income Margin

-10.14%

Return on Equity

-15.47%

Return on Capital

-8.80%

Return on Assets

-10.71%

Earnings Yield

-30.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£3.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

932.82M

Volume

48.27K

Avg. Volume

492.09K

Financials (TTM)

Gross Profit

£6.20M

Operating Income

-£1.47M

EBITDA

-£1.44M

Operating Cash Flow

£1.22M

Capital Expenditure

-£95.00K

Free Cash Flow

£1.13M

Cash & ST Invst.

£361.00K

Total Debt

£587.00K

Surgical Innovations Group Plc Performance Analysis

Surgical Innovations Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 11,340,00024.3%
20232023-12-31GBP 12,014,0005.9%
20242024-12-31GBP 11,945,000-0.6%
20252025-12-31GBP 11,602,000-2.9%
Surgical Innovations Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-6.6%
Q22025-06-306.5%
Q42025-12-31-11.2%
Q22026-06-3010.3%
Surgical Innovations Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP 0.00N/A
20232023-12-31GBP -0.00N/A
20242024-12-31GBP -0.00250.0%
20252025-12-31GBP -0.00-52.4%
Surgical Innovations Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-220.0%
Q22025-06-30100.0%
Q42025-12-31N/A
Q22026-06-30100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£6.02M

-2.5%

Gross Profit

£1.75M

-14.1%

Gross Margin

29.04%

N/A

Market Cap

£3.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£45.50K

N/A

Employees

82

N/A

Net Income

-£248.00K

+49.1%

EBITDA

-£230.00K

-100.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£361.00K

+55.6%

Total Debt

£587.00K

-35.6%

Accounts Receivable

£1.90M

-22.2%

Inventory

£1.68M

-49.2%

Long Term Debt

£301.00K

-64.2%

Short Term Debt

£286.00K

-62.3%

Return on Assets

-10.71%

N/A

Return on Invested Capital

-12.71%

N/A

Free Cash Flow

£196.00K

+134.8%

Operating Cash Flow

£200.00K

+138.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CRTX.LCRISM Therapeutics Corporation
£0.10+5.26%
TCF.LTheracryf Plc
£0.00+0.00%
CNSL.LCambridge Nutritional Sciences plc
£0.02-3.23%
N4P.LN4 Pharma Plc
£0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$32.77-0.94%
HYGiShares Trust - iShares iBoxx $ High Yieldorate Bond ETF
$76.69-0.24%
NUNu Holdings
$12.86+1.58%
NXLNexalin Technology
$7.85+83.39%

Questions About SUN

What is the current price of Surgical Innovations Group Plc?

Surgical Innovations Group Plc is trading at £0.00 per share.

What is the 52-week range for Surgical Innovations Group Plc?

Over the past 52 weeks, Surgical Innovations Group Plc has traded between £0.00 and £0.01.

How much debt does Surgical Innovations Group Plc have?

As of the most recent reporting period, Surgical Innovations Group Plc reported total debt of £665.00K.

How much cash does Surgical Innovations Group Plc have on hand?

Surgical Innovations Group Plc reported £813.00K in cash and cash equivalents in its most recent financial results.

What is Surgical Innovations Group Plc’s dividend yield?

Surgical Innovations Group Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services